Concepedia

Nan Mou

NM

8

Publications

224

Citations

8

H-Index

2020

Active since

Affiliations

Tianjin Medical University(Current)

Tianjin First Center Hospital

Army Medical University

Southwest Hospital

City Of Hope National Medical Center

Nan Mou is an author at Tianjin Medical University specializing in microbiology, drug resistance, and pathogenesis.

Top concepts

Publications per year

2020–2023

8

Publications

8

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant

Pengjiang Liu, Meijing Liu, Cuicui Lyu et al. · Frontiers in Oncology · 2020 · 57 citations · Full text

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia

Jia Wang, Nan Mou, Zhenxing Yang et al. · British Journal of Haematology · 2020 · 50 citations · Full text

Luteolin attenuates the pathogenesis of Staphylococcus aureus by interfering with the agr system

Yuan Qian, Wei Feng, Yu Wang et al. · Microbial Pathogenesis · 2022 · 33 citations

, , +10

Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection

Rui Cui, Cuicui Lyu, Qing Li et al. · Hematological Oncology · 2020 · 24 citations · Full text

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity

Lin Cheng, Bangbi Weng, Changsheng Jia et al. · Frontiers in Pharmacology · 2022 · 18 citations · Full text

Rows per page

1–5 of 8